Skip to main content

Table 1 Tigecycine MICs of isolates obtained by different testing methodologies or medium types

From: Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline

 

Number of isolates with MICs (mg l− 1)

Organism (n)

Method

<0. 1

0.1

0.2

0.5

1

2

4

8

16

32

64

All isolates (84)

BMD1

2

10

20

13

19

4

7

7

1

1

0

BMD2

0

6

19

12

14

15

7

7

3

1

0

Etest

2

15

24

8

12

7

8

7

1

0

0

AD

0

1

11

17

16

13

11

2

9

3

1

K. pneumoniae (29)

BMD1

0

0

3

4

10

2

2

6

1

1

0

BMD2

0

0

2

2

6

7

2

6

3

1

0

Etest

0

0

6

5

7

1

3

6

1

0

0

AD

0

0

0

2

6

9

2

2

7

0

1

E. coli (30)

BMD1

0

7

14

8

1

0

0

0

0

0

0

BMD2

0

3

13

9

4

1

0

0

0

0

0

Etest

1

10

16

2

1

0

0

0

0

0

0

AD

0

1

8

11

9

1

0

0

0

0

0

A. baumannii (25)

BMD1

2

3

3

1

8

2

5

1

0

0

0

BMD2

0

3

4

1

4

7

5

1

0

0

0

Etest

1

5

2

1

4

6

5

1

0

0

0

AD

0

0

3

4

1

3

9

0

2

3

0

  1. BMD1 Broth microdilution –Difco, BMD2 Broth microdilution -Condalab, AD Agar dilution